Page last updated: 2024-09-03

substance p (5-11), pglu(5)-mephe(8)-megly(9)- and flupenthixol

substance p (5-11), pglu(5)-mephe(8)-megly(9)- has been researched along with flupenthixol in 1 studies

Compound Research Comparison

Studies
(substance p (5-11), pglu(5)-mephe(8)-megly(9)-)
Trials
(substance p (5-11), pglu(5)-mephe(8)-megly(9)-)
Recent Studies (post-2010)
(substance p (5-11), pglu(5)-mephe(8)-megly(9)-)
Studies
(flupenthixol)
Trials
(flupenthixol)
Recent Studies (post-2010) (flupenthixol)
4700929128138

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altier, N; Stewart, J1

Other Studies

1 other study(ies) available for substance p (5-11), pglu(5)-mephe(8)-megly(9)- and flupenthixol

ArticleYear
Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:1

    Topics: Adrenergic Antagonists; Amphetamine; Analgesia; Analgesics, Opioid; Animals; Benzazepines; Dopamine Antagonists; Flupenthixol; Male; Morphine; Nucleus Accumbens; Peptide Fragments; Pyrrolidonecarboxylic Acid; Raclopride; Rats; Rats, Wistar; Salicylamides; Substance P; Ventral Tegmental Area

1998